Dl-Tryptophan

Dl-Tryptophan

SCHEMBL27709285

N=C(N)NCCCC(N)C(=O)O.NC(Cc1c[nH]c2ccccc12)C(=O)O.NC(Cc1ccccc1)C(=O)O.NCCCCC(N)C(=O)O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Dl-Tryptophan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ MPO P05164 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ PMP22 Q01453 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ HIF1A Q16665 1/20 0.57
▸ MC4R P32245 2/20 0.52
▸ MC5R P33032 1/20 0.52
▸ MC3R P41968 1/20 0.52
▸ GHSR Q92847 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tryptophan SCHEMBL27641188 1.00 KDM4E (0.57) KDM4EMEN1LMNAMPOMAPT
Dl-Tryptophan SCHEMBL28366886 1.00 KDM4E (0.57) KDM4EMEN1LMNAMPOMAPT
Dl-Tryptophan SCHEMBL28250969 0.97 KDM4E (0.54) KDM4EMEN1LMNAMPOMAPT
Tryptophan SCHEMBL28205930 0.97 KDM4E (0.53) KDM4EMEN1LMNAMPOMAPT
Tryptophan SCHEMBL27671666 0.96 KDM4E (0.61) KDM4EMEN1LMNAMPOMAPT
Dl-Tryptophan SCHEMBL28466764 0.96 KDM4E (0.61) KDM4EMEN1LMNAMPOMAPT
Dl-Tryptophan SCHEMBL27093065 0.96 KDM4E (0.61) KDM4EMEN1LMNAMPOMAPT
Dl-Tryptophan SCHEMBL22587382 0.96 KDM4E (0.61) KDM4EMEN1LMNAMPOMAPT
Dl-Tryptophan SCHEMBL27660745 0.95 KMT2A (0.63) KDM4EMEN1LMNAMPOMAPT
Dl-Tryptophan SCHEMBL28861116 0.94 KMT2A (0.58) KDM4EMEN1LMNAMPOMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1938042-B Use of aromatic cationic peptides for the manufacture of a medicament for the reduction of oxidative damage CORNELL RES FOUNDATION INC 2010-06-02 — — CN disclosed
CN-100536909-C method for preventing mitochondrial permeability transition CORNELL RES FOUNDATION INC CLI (US) 2009-09-09 — — CN disclosed
CN-101214380-A Method and carrier complexes for delivering molecules to cells CORNELL RES FOUNDATION INC (US) 2008-07-09 — — CN disclosed
Send feedback